Acceleron Pharmaceuticals
Acceleron aims to transform the lives of people suffering from cancer and orphan diseases by discovering and developing innovative therapies.
Acceleron scientists have world-leading expertise in developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red…
Videos
-
Pharma CEO: Daraprim Price Hike is ‘Terribly Unfortunate’
What one pharma executive thinks about the Daraprim drug pricing controversy.
December 14, 2015More -
From Venom to Victory: The NPS Pharma Turnaround Story
The stunning turnaround of NPS Pharma, as told by the CEO who recently sold the company for $5.3B.
November 5, 2015More
Privcap Email Updates
Subscribe to receive email notifications whenever new talks are published.